Yasuo Hirayama

1.9k total citations
61 papers, 1.3k citations indexed

About

Yasuo Hirayama is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Yasuo Hirayama has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 20 papers in Oncology and 14 papers in Genetics. Recurrent topics in Yasuo Hirayama's work include Platelet Disorders and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Yasuo Hirayama is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Hematopoietic Stem Cell Transplantation (7 papers). Yasuo Hirayama collaborates with scholars based in Japan, Greece and Germany. Yasuo Hirayama's co-authors include Yoshiro Niitsu, Sumio Sakamaki, Takuya Matsunaga, Hiroyuki Kuroda, Kyuhei Kohda, Masayoshi Kobune, Rishu Takimoto, Junji Kato, Takehide Akiyama and Akihito Fujimi and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Yasuo Hirayama

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yasuo Hirayama Japan	15	705	355	332	260	255	61	1.3k
Kazuma Ikeda Japan	23	446 0.6×	470 1.3×	390 1.2×	476 1.8×	204 0.8×	106	1.6k
Gareth L. Howells United Kingdom	16	528 0.7×	163 0.5×	241 0.7×	288 1.1×	240 0.9×	24	1.2k
Mackenzie Bowman Canada	18	760 1.1×	166 0.5×	462 1.4×	121 0.5×	169 0.7×	45	1.4k
M. A. Boogaerts Belgium	20	823 1.2×	242 0.7×	266 0.8×	232 0.9×	262 1.0×	29	1.2k
Serena Bugatti Italy	28	301 0.4×	289 0.8×	258 0.8×	655 2.5×	244 1.0×	89	2.1k
Apostolos Kontzias United States	15	379 0.5×	355 1.0×	295 0.9×	409 1.6×	170 0.7×	31	1.3k
June Li United States	17	654 0.9×	115 0.3×	220 0.7×	199 0.8×	119 0.5×	37	1.0k
S Fukuhara Japan	19	352 0.5×	250 0.7×	358 1.1×	408 1.6×	267 1.0×	40	1.3k
Mojtaba Akhtari United States	19	444 0.6×	394 1.1×	290 0.9×	263 1.0×	190 0.7×	77	1.2k
Predrag Musikic Slovenia	10	322 0.5×	161 0.5×	259 0.8×	308 1.2×	107 0.4×	12	1.2k

Countries citing papers authored by Yasuo Hirayama

Since Specialization

Citations

This map shows the geographic impact of Yasuo Hirayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Hirayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Hirayama more than expected).

Fields of papers citing papers by Yasuo Hirayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Hirayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Hirayama. The network helps show where Yasuo Hirayama may publish in the future.

Co-authorship network of co-authors of Yasuo Hirayama

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Hirayama. A scholar is included among the top collaborators of Yasuo Hirayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Hirayama. Yasuo Hirayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sato, Tsutomu, Yasuhiro Nagamachi, Satoshi Iyama, et al.. (2016). A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma. Cancer Chemotherapy and Pharmacology. 78(5). 1041–1049. 4 indexed citations

Koike, Kazuhiko, Toshiro Kusakabe, Yasuo Hirayama, et al.. (2015). A new once-a-day fentanyl citrate patch (Fentos® Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch. Supportive Care in Cancer. 24(3). 1053–1059. 6 indexed citations

Horiguchi, Hiroto, Kohichi Takada, Yusuke Kamihara, et al.. (2014). Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma. Case Reports in Oncology. 7(2). 565–570. 9 indexed citations

Horiguchi, Hiroto, Kohichi Takada, Rishu Takimoto, et al.. (2014). Radiation-Induced Leiomyosarcoma in Prostate After Brachytherapy for Prostatic Adenocarcinoma. Annals of Oncology. 25. v89–v89. 1 indexed citations

Hirayama, Yasuo, Toshiro Kusakabe, Kazuhiko Koike, et al.. (2013). A Survey of Patients Who Were Referred to Our Palliative Care Division From Other Hospitals and Appeared to Have Obvious Indications for Cancer Chemotherapies. American Journal of Hospice and Palliative Medicine®. 31(8). 804–807. 2 indexed citations

Wada, Yuko, Yasuo Hirayama, Yuichi Konuma, et al.. (2007). Long Term Remission Survival with a Case of Rectal Carcinoid Tumor with Metastasis in the Soft Tissue Effectively Treated with the Combination Therapy of Irinotecan/5-fluorouracil/levofolinate Followed by Resection. Nihon Naika Gakkai Zasshi. 96(11). 2513–2515. 3 indexed citations

Iyama, Satoshi, Takuya Matsunaga, Akihito Fujimi, et al.. (2005). [Successful treatment with oral ribavirin of adenovirus-associated hemophagocytic syndrome in a stem cell transplantation recipient].. PubMed. 46(5). 363–7. 7 indexed citations

Kawaguchi, Satoshi, Satoshi Nagoya, Takuro Wada, et al.. (2004). Abdominal small round cell tumor with osteoid and EWS/FLI1. Human Pathology. 35(6). 773–775. 13 indexed citations

Murase, Kazuyuki, Takuya Matsunaga, Naoko Takeuchi, et al.. (2004). [Second hematologic response and disappearance of the ABL gene mutant clone by cessation of imatinib in a CML patient with resistance to imatinib].. PubMed. 45(9). 1028–32. 1 indexed citations

10.

Matsunaga, Takuya, Naofumi Takemoto, Tsutomu Sato, et al.. (2003). Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nature Medicine. 9(9). 1158–1165. 445 indexed citations

11.

Hirayama, Yasuo, Sumio Sakamaki, Yasushi Tsuji, Takuya Matsunaga, & Yoshiro Niitsu. (2003). Cyclic Platelet and Leukocyte Count Oscillation in Chronic Myelocytic Leukemia Regulated by the Negative Feedback of Transforming Growth Factor β. International Journal of Hematology. 77(1). 71–74. 6 indexed citations

12.

Chiba, Hiroki, Rishu Takimoto, Yasushi Sato, et al.. (2003). Gamma/Delta T-Cell Lymphoma of Duodenal Bulb. Gastrointestinal Endoscopy. 58(4). 616–620. 2 indexed citations

13.

Kuroda, Hiroyuki, Takuya Matsunaga, Takeshi Terui, et al.. (2003). Decrease of Smad4 gene expression in patients with essential thrombocythaemia may cause an escape from suppression of megakaryopoiesis by transforming growth factor‐β1. British Journal of Haematology. 124(2). 211–220. 14 indexed citations

14.

Murase, Kazuyuki, Takuya Matsunaga, Tsutomu Sato, et al.. (2003). Allogeneic bone marrow transplantation in a patient with T-prolymphocytic leukemia with small-intestinal involvement. International Journal of Clinical Oncology. 8(6). 391–394. 11 indexed citations

15.

Hirayama, Yasuo, Takuya Matsunaga, Katsuhisa Kogawa, et al.. (2002). A Pleural Effusion Caused by Fibrous Hematopoietic Tumor Successfully Treated With Prednisolone in a Patient With Agnogenic Myeloid Metaplasia With Myelofibrosis. International Journal of Hematology. 75(3). 305–308. 2 indexed citations

16.

Kohda, Kyuhei, Sumio Sakamaki, Takuya Matsunaga, et al.. (2001). Long-Term Survival and Late-Onset Complications of Cancer Patients Treated With High-Dose Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation. International Journal of Hematology. 73(2). 251–257. 8 indexed citations

17.

Sakamaki, Sumio, Yasuo Hirayama, Takuya Matsunaga, et al.. (1999). Transforming Growth Factor-β1 (TGF-β1) Induces Thrombopoietin From Bone Marrow Stromal Cells, Which Stimulates the Expression of TGF-β Receptor on Megakaryocytes and, in Turn, Renders Them Susceptible to Suppression by TGF-β Itself With High Specificity. Blood. 94(6). 1961–1970. 66 indexed citations

18.

Kawaguchi, Yoko, et al.. (1997). Comparative Study on Oral Health Status of Three Ethnic Groups of Schoolchildren in Japan and Korea. JOURNAL OF DENTAL HEALTH. 47(5). 675–682. 1 indexed citations

19.

Hirayama, Yasuo, et al.. (1993). Cytokine mRNA expression of bone marrow stromal cells from patients with aplastic anaemia and myelodysplastic syndrome. British Journal of Haematology. 85(4). 676–683. 37 indexed citations

20.

Matsunaga, Takuya, Sumio Sakamaki, Yasuo Hirayama, et al.. (1992). Optimal Collection of Peripheral Blood Stem Cells By Assessing CD34? cells in Cancer Patients Administered with G-CSF after Chemotherapy. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact